Neurology Edition: Top Headlines for July 18, 2022

In this week’s edition, Break Through Cancer awards $50M to fund a ‘radical collaboration’ in cancer research; the FDA grants a breakthrough device designation for an MS plasma test; App-based mental exercises may improve cognitive impairment; and more.

Read the full coverage here:

Break Through Cancer awards $50M to fund ‘radical collaboration’ in cancer research

FDA grants breakthrough device designation for MS plasma test

App-based mental exercises improve cognitive impairment

Neurodevelopment in infants with CHD may be predicted in utero

Benefits of ticagrelor, aspirin for stroke outweigh risks over 30 days

References:

Press Release

Press Release

Press Release

Healio Interview

Wang Y, et al. Neurology. 2022;doi:10.1212/WNL.0000000000200355.